BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernández E, Toledo JR, Méndez L, González N, Parra F, Martín-Alonso JM, Limonta M, Sánchez K, Cabrales A, Estrada MP, Rodríguez-Mallón A, Farnós O. Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine. PLoS One 2013;8:e56417. [PMID: 23460801 DOI: 10.1371/journal.pone.0056417] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Baha S, Zhang M, Behloul N, Liu Z, Wei W, Meng J. Efficient production and characterization of immunogenic HEV-PCV2 chimeric virus-like particles. Veterinary Microbiology 2022. [DOI: 10.1016/j.vetmic.2022.109410] [Reference Citation Analysis]
2 Mirzaeinia S, Pazhang M, Imani M, Chaparzadeh N, Amani-ghadim AR. Improving the stability of uricase from Aspergillus flavus by osmolytes: Use of response surface methodology for optimization of the enzyme stability. Process Biochemistry 2020;94:86-98. [DOI: 10.1016/j.procbio.2020.04.020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Behloul N, Baha S, Liu Z, Wei W, Zhu Y, Rao Y, Shi R, Meng J. Design and development of a chimeric vaccine candidate against zoonotic hepatitis E and foot-and-mouth disease. Microb Cell Fact 2020;19:137. [PMID: 32653038 DOI: 10.1186/s12934-020-01394-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Parker SA, Maloy MH, Tome-amat J, Bardliving CL, Batt CA, Lanz KJ, Olesberg JT, Arnold MA. Optimization of norovirus virus-like particle production in Pichia pastoris using a real-time near-infrared bioprocess monitor. Biotechnol Progress 2016;32:518-26. [DOI: 10.1002/btpr.2224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kim H, Kim H. Yeast as an expression system for producing virus-like particles: what factors do we need to consider? Lett Appl Microbiol 2017;64:111-23. [DOI: 10.1111/lam.12695] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
6 Lin SY, Chung YC, Chiu HY, Chi WK, Chiang BL, Hu YC. Evaluation of the stability of enterovirus 71 virus-like particle. J Biosci Bioeng 2014;117:366-71. [PMID: 24140131 DOI: 10.1016/j.jbiosc.2013.08.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
7 Miao Q, Qi R, Veldkamp L, Ijzer J, Kik ML, Zhu J, Tang A, Dong D, Shi Y, van Oers MM, Liu G, Pijlman GP. Immunogenicity in Rabbits of Virus-Like Particles from a Contemporary Rabbit Haemorrhagic Disease Virus Type 2 (GI.2/RHDV2/b) Isolated in The Netherlands. Viruses 2019;11:E553. [PMID: 31207978 DOI: 10.3390/v11060553] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Nakanishi K, Tomita M, Tsumoto K. Membrane fusion and infection abilities of baculovirus virions are preserved during freezing and thawing in the presence of trehalose. Biosci Biotechnol Biochem 2020;84:686-94. [PMID: 31852366 DOI: 10.1080/09168451.2019.1704396] [Reference Citation Analysis]
9 Angrand G, Quillévéré A, Loaëc N, Daskalogianni C, Granzhan A, Teulade-Fichou MP, Fahraeus R, Prado Martins R, Blondel M. Sneaking Out for Happy Hour: Yeast-Based Approaches to Explore and Modulate Immune Response and Immune Evasion. Genes (Basel) 2019;10:E667. [PMID: 31480411 DOI: 10.3390/genes10090667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Al-Barwani F, Young SL, Baird MA, Larsen DS, Ward VK. Mannosylation of virus-like particles enhances internalization by antigen presenting cells. PLoS One 2014;9:e104523. [PMID: 25122183 DOI: 10.1371/journal.pone.0104523] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
11 Lua LH, Connors NK, Sainsbury F, Chuan YP, Wibowo N, Middelberg AP. Bioengineering virus-like particles as vaccines. Biotechnol Bioeng 2014;111:425-40. [PMID: 24347238 DOI: 10.1002/bit.25159] [Cited by in Crossref: 188] [Cited by in F6Publishing: 175] [Article Influence: 20.9] [Reference Citation Analysis]
12 Müller C, Hrynkiewicz R, Bębnowska D, Maldonado J, Baratelli M, Köllner B, Niedźwiedzka-Rystwej P. Immunity against Lagovirus europaeus and the Impact of the Immunological Studies on Vaccination. Vaccines (Basel) 2021;9:255. [PMID: 33805607 DOI: 10.3390/vaccines9030255] [Reference Citation Analysis]